Compare USAS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USAS | OSUR |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 174.3M |
| IPO Year | N/A | 1986 |
| Metric | USAS | OSUR |
|---|---|---|
| Price | $5.07 | $2.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $4.08 | $3.00 |
| AVG Volume (30 Days) | ★ 4.2M | 688.5K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $104,867,000.00 | ★ $125,703,000.00 |
| Revenue This Year | $20.47 | N/A |
| Revenue Next Year | $91.15 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.92 | $2.08 |
| 52 Week High | $6.24 | $4.22 |
| Indicator | USAS | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 43.20 |
| Support Level | $5.64 | $2.41 |
| Resistance Level | $6.24 | $2.50 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | -0.11 | 0.00 |
| Stochastic Oscillator | 12.55 | 18.00 |
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.